Drug Testing and Analysis

Cover image for Vol. 3 Issue 11-12

Special Issue: 29th Cologne Workshop: Advances in Sports Drug Testing

November-December 2011

Volume 3, Issue 11-12

Pages 755–905

  1. Editorial

    1. Top of page
    2. Editorial
    3. Research articles
    4. Short communications
    5. Research articles
    6. Short communications
    7. Research articles
    8. Short communications
    9. Research articles
  2. Research articles

    1. Top of page
    2. Editorial
    3. Research articles
    4. Short communications
    5. Research articles
    6. Short communications
    7. Research articles
    8. Short communications
    9. Research articles
    1. Circulating microRNAs as long-term biomarkers for the detection of erythropoiesis-stimulating agent abuse (pages 771–776)

      Nicolas Leuenberger, Nicolas Jan, Sylvain Pradervand, Neil Robinson and Martial Saugy

      Article first published online: 24 NOV 2011 | DOI: 10.1002/dta.370

      This study showed an increase of a specific circulating miRNA, miR-144, in plasma samples after a single C.E.R.A injection. Moreover, this increase indicated that the miRNA method might be use for long term detection.

  3. Short communications

    1. Top of page
    2. Editorial
    3. Research articles
    4. Short communications
    5. Research articles
    6. Short communications
    7. Research articles
    8. Short communications
    9. Research articles
    1. Zeranol: doping offence or mycotoxin? A case-related study (pages 777–783)

      Mario Thevis, Gregor Fußhöller and Wilhelm Schänzer

      Article first published online: 17 NOV 2011 | DOI: 10.1002/dta.352

      Thumbnail image of graphical abstract

      The detection of zeranol in urine samples might result from mycotoxin-contaminated cereal products. A differentiation of an illicit use as anabolic agent from an unintended ingestion of mycotoxin-colonized food is supported by the analysis of indicative metabolites and relative abundances.

  4. Research articles

    1. Top of page
    2. Editorial
    3. Research articles
    4. Short communications
    5. Research articles
    6. Short communications
    7. Research articles
    8. Short communications
    9. Research articles
    1. Detection of doping with rhGH: Excretion study with WADA-approved kits (pages 784–790)

      Jing Jing, Sheng Yang, Xinmiao Zhou, Chunji He, Lisi Zhang, Youxuan Xu, Minhao Xie, Yi Yan, Hao Su and Moutian Wu

      Article first published online: 6 DEC 2011 | DOI: 10.1002/dta.359

      Thumbnail image of graphical abstract

      All data from this excretion study and the reference data from our routine and research were measured with WADA approved Kit 1 and Kit 2. The figures and tebles show the statistical results of the concentrations of GH isoforms and their ratios, which support the time window of detection after administration of rhGH preparation in this excretion study.

    2. Identification of fibroblast growth factor 1 (FGF-1) in a black market product (pages 791–797)

      Katja Walpurgis, Andreas Thomas, Tim Laussmann, Luis Horta, Sabine Metzger, Wilhelm Schänzer and Mario Thevis

      Article first published online: 13 OCT 2011 | DOI: 10.1002/dta.364

      Thumbnail image of graphical abstract

      This report describes the detection of an unknown truncated or modified form of FGF-1 in an injection vial confiscated by the German customs. The identification of the protein was accomplished by different proteomic approaches including gel electrophoresis, in-gel proteolysis and nano-liquid chromatography high-resolution/high-accuracy Orbitrap mass spectrometry.

    3. Doping control of biosimilar epoetin kappa and other recombinant erythropoietins after intravenous application (pages 798–805)

      Masato Okano, Mitsuhiko Sato, Emi Kaneko and Shinji Kageyama

      Article first published online: 19 OCT 2011 | DOI: 10.1002/dta.369

      Thumbnail image of graphical abstract

      Intravenous administration studies of epoetin alfa, epoetin beta and the new biosimilar epoetin kappa were performed to test the applicability of the two WADA-approved methods (IEF-, SDS-PAGE). The isoform bands of epoetin kappa expanded more widely towards the basic area in the IEF-PAGE and epoetin kappa contains isoforms with a higher molecular mass than those of other epoetins. The intravenous injections of epoetins showed shorter clearance times and the detection window of SDS-PAGE is longer than that of IEF-PAGE.

    4. Dried blood spots (DBS) for doping control analysis (pages 806–813)

      Andreas Thomas, Hans Geyer, Sven Guddat, Wilhelm Schänzer and Mario Thevis

      Article first published online: 5 OCT 2011 | DOI: 10.1002/dta.342

      Thumbnail image of graphical abstract

      Dried blood spot sampling in doping controls provides the advantageous potential to obtain information of circulating drugs in pre- or post-composition testing with minimal invasive sample collection and superior transfer/ storage conditions.

    5. Carbon isotope ratio determination and investigation of seized testosterone preparations (pages 814–819)

      Guro Forsdahl, Christian Östreicher, Martina Koller and Günter Gmeiner

      Article first published online: 18 NOV 2011 | DOI: 10.1002/dta.373

      Thumbnail image of graphical abstract

      The content and δ 13CVPDB values of testosterone were determined for black marked testosterone products collected in Austria. For a significant amount of the products, the declared ingredients differed from the actual content. More than half of the preparations were found to have δ 13CVPDB values of testosterone in the range reported for endogenous urinary steroids.

    6. Determination of salbutamol and salbutamol glucuronide in human urine by means of liquid chromatography-tandem mass spectrometry (pages 820–827)

      Ute Mareck, Sven Guddat, Anne Schwenke, Simon Beuck, Hans Geyer, Ulrich Flenker, Jimmi Elers, Vibeke Backer, Mario Thevis and Wilhelm Schänzer

      Article first published online: 14 NOV 2011 | DOI: 10.1002/dta.367

      Thumbnail image of graphical abstract

      An assay for the determination of salbutamol and its glucuronide in human urine by means of direct injection utilizing liquid chromatography tandem mass spectrometry is presented and the excretion of small amounts of salbutamol glucuronide in human urine following the administration of salbutamol was proven.

    7. Detection of dihydrotestosterone gel, oral dehydroepiandrosterone, and testosterone gel misuse through the quantification of testosterone metabolites released after alkaline treatment (pages 828–835)

      Andreu Fabregat, Oscar J. Pozo, Pieter Van Renterghem, Peter Van Eenoo, Josep Marcos, Jordi Segura and Rosa Ventura

      Article first published online: 13 OCT 2011 | DOI: 10.1002/dta.351

      Thumbnail image of graphical abstract

      The usefulness of four testosterone metabolites released after alkaline treatment has been evaluated for the detection of the misuse of single doses of dihydrotestosterone (DHT) gel, oral dehydroepiandrosterone (DHEA) and testosterone gel. Whereas limited efficacy was observed for DHT gel, the use of these metabolites allowed for increasing the retrospectivity in oral DHEA and testosterone gel administration.

    8. High-throughput screening for various classes of doping agents using a new ‘dilute-and-shoot’ liquid chromatography-tandem mass spectrometry multi-target approach (pages 836–850)

      S. Guddat, E. Solymos, A. Orlovius, A. Thomas, G. Sigmund, H. Geyer, M. Thevis and W. Schänzer

      Article first published online: 2 DEC 2011 | DOI: 10.1002/dta.372

      Thumbnail image of graphical abstract

      A new multi-target approach based on (LC-(ESI)-MS/MS) is presented to screen for various classes of prohibited substances using direct injection of urine specimens. The assay enables the detection of classic groups of drugs, e.g. diuretics, beta2-agonists, stimulants and narcotics at concentration levels far below the required limits. Additionally, more challenging and various new target compounds could be implemented, e.g. stimulant conjugates, the plasma volume expanders dextran and hydroxyethyl starch, the selective androgen receptor modulator andarine, a metabolite of growth hormone releasing peptide (GHRP-2), 5-amino-4-imidazolecarboxyamide ribonucleoside (AICAR) and conjugates of di(2-ethylhexyl) phthalate (DEHP) metabolites indicating for illicit blood-transfusion are analysed.

    9. Urinary concentrations of ethyl glucuronide and ethyl sulfate as thresholds to determine potential ethanol-induced alteration of steroid profiles (pages 851–856)

      D. Thieme, J. Große, L. Keller and M. Graw

      Article first published online: 29 DEC 2011 | DOI: 10.1002/dta.396

      Thumbnail image of graphical abstract

      The ethanol consumption marker ethylglucuronide was found to be a good marker for a potential alcohol induced alteration of steroid concentration in urine.

    10. Comprehensive 2-dimensional gas chromatography fast quadrupole mass spectrometry (GC × GC-qMS) for urinary steroid profiling: Mass spectral characteristics with chemical ionization (pages 857–867)

      Ying Zhang, Herbert J. Tobias, Richard J. Auchus and J. Thomas Brenna

      Article first published online: 6 DEC 2011 | DOI: 10.1002/dta.380

      Thumbnail image of graphical abstract

      Comprehensive two dimensional gas chromatography coupled to fast quadrupole mass spectrometry (GC×GC-qMS) was evaluated for analysis of urinary steroids using electron ionization (EI) and positive chemical ionization with NH3 (PCI-NH3). PCI-NH3 yielded highly specific mass spectra with characteristic pseudomolecular ions for steroid acetates which complement EI spectra for structural characterization.

  5. Short communications

    1. Top of page
    2. Editorial
    3. Research articles
    4. Short communications
    5. Research articles
    6. Short communications
    7. Research articles
    8. Short communications
    9. Research articles
    1. Stimulating luteinizing hormone (pages 868–872)

      Catrin Goebel

      Article first published online: 6 DEC 2011 | DOI: 10.1002/dta.393

      Thumbnail image of graphical abstract

      Low molecular weight luteinizing hormone (LMWLH) receptor agonists could be of interest as a potential doping substance for athletes. Precursor ion monitoring liquid chromatography tandem mass spectrometry method was proposed to detect a broad range of potential LMWLH receptor agonists. The method was tested against a selection of urine samples to ascertain potential problems with background analytes interfering with the compounds of interests. The two available LMWLH receptor agonists could be detected at concentrations of 100 ng/mL in urine samples.

    2. Studies of methylhexaneamine in supplements and geranium oil (pages 873–876)

      A. Lisi, N. Hasick, R. Kazlauskas and C. Goebel

      Article first published online: 6 DEC 2011 | DOI: 10.1002/dta.392

      Thumbnail image of graphical abstract

      A number of supplements are now available which are sold as fat burners or pre-workout boosters and contain stimulants which are banned in sport. Many contain methylhexaneamine under one of many pseudonyms including Geranamine, geranium oil or extract, or a number of chemical names such as 1,3-dimethylpentylamine.

      This communication shows that geranium oils do not contain methylhexaneamine and that products labeled as containing geranium oil but which contain methylhexaneamine can only arise from addition of synthetic material.

  6. Research articles

    1. Top of page
    2. Editorial
    3. Research articles
    4. Short communications
    5. Research articles
    6. Short communications
    7. Research articles
    8. Short communications
    9. Research articles
    1. Urinary excretion of exogenous glycerol administration at rest (pages 877–882)

      Karsten Koehler, Hans Braun, Markus de Marees, Hans Geyer, Mario Thevis, Joachim Mester and Wilhelm Schaenzer

      Article first published online: 19 OCT 2011 | DOI: 10.1002/dta.355

      Thumbnail image of graphical abstract

      Glycerol was administered and hydration status and plasma and urinary glycerol concentrations were measured. Plasma volume increased but the effects on haemoglobin and haematocrit were rather small. Urinary glycerol concentrations were significantly higher than in placebo until 16.9 ± 1.0 h post administration.

    2. The overlooked difference between human endogenous and recombinant erythropoietins and its implication for sports drug testing and pharmaceutical drug design (pages 883–891)

      Christian Reichel

      Article first published online: 2 DEC 2011 | DOI: 10.1002/dta.388

      Thumbnail image of graphical abstract

      A profound structural difference between human endogenous EPO and literally all recombinant erythropoietins was discovered and visualized by SDS-PAGE and sequential exoglycosidase digestion. According to these data all recombinant EPO pharmaceuticals currently produced worldwide significantly differ from human endogenous epoetins. Aside from its applicability in sports drug testing the discovery might prove useful for the production of recombinant epoetins with closer structural identity to human EPO.

  7. Short communications

    1. Top of page
    2. Editorial
    3. Research articles
    4. Short communications
    5. Research articles
    6. Short communications
    7. Research articles
    8. Short communications
    9. Research articles
    1. Di(2-ethylhexyl) phthalate metabolites as markers for blood transfusion in doping control: Intra-individual variability of urinary concentrations (pages 892–895)

      E. Solymos, S. Guddat, H. Geyer, A. Thomas, M. Thevis and W. Schänzer

      Article first published online: 6 DEC 2011 | DOI: 10.1002/dta.377

      Thumbnail image of graphical abstract

      Intra-individual variability of urinary di(2-ethylhexyl) phthalate (DEHP) metabolites were tested among seven volunteers during one week to investigate the possibility of increased DEHP exposure via non-medical routes. Quantification of the metabolites was accomplished after enzymatic hydrolysis of urinary glucuronide conjugates and direct injection using isotope-dilution liquid-chromatography/tandem mass spectrometry.

  8. Research articles

    1. Top of page
    2. Editorial
    3. Research articles
    4. Short communications
    5. Research articles
    6. Short communications
    7. Research articles
    8. Short communications
    9. Research articles
    1. A rapid analytical method for the detection of plasma volume expanders and mannitol based on the urinary saccharides and polyalcohols profile (pages 896–905)

      Monica Mazzarino, Ilaria Fiacco, Xavier de la Torre and Francesco Botrè

      Article first published online: 8 DEC 2011 | DOI: 10.1002/dta.387

      Thumbnail image of graphical abstract

      This study presents a screening procedure for the detection of saccharides and polyalcohols in human urine in the framework of doping control analysis. The proposed method was set up and validated to detect the abuse of dextran, hydroxyethyl starch and mannitol and involves only one enzymatic hydrolysis step and the direct injection into a LC-MS/MS system. The method could be used also as HES and dextran confirmation method avoiding the need for the complex confirmation procedures used until now.

SEARCH

SEARCH BY CITATION